2021/04/28

The National Center of Neurology and Psychiatry reported the results of biomarker research on autoimmune diseases

2020/06/10

Signed a contracted research and development agreement with AMED to establish basic technology for manufacturing highly functional genome-edited T cells

2020/06/08

Participation in the development project of comprehensive evaluation method of COVID-19 virus antigen-specific immune responses for selection of high-risk patients

2020/04/08

Cellectis and Repertoire Genesis execute a Collaboration and Option to License Agreement with respect to Cellectis' TAL Nuclease technology

2019/11/07

Notice Regarding Collaboration Agreement with QIAGEN on Companion Diagnostics

2019/09/30

Notice Regarding Joint R & D Agreement and Capital Alliance with Zenyaku Kogyo Co., Ltd.

2019/06/20

Researchers of Akita University used our BCR repertoire analysis and their paper has published in "Scientific Reports".

2019/05/09

Iwate Medical University researchers using our TCR/BCR repertoire analysis publish a scientific paper in "Human Vaccines & Immunotherapeutics"

2019/05/07

Prof. Kazuhiro Kakimi article is in the Top 100 Scientific Reports oncology papers in 2018

2019/03/29

Our collaborator to present a study at the AACR Annual Meeting 2019